ProQR Therapeutics N.V. (PRQR)

ProQR Therapeutics Revenue

ProQR Therapeutics had revenue of 4.74M EUR in the quarter ending March 31, 2025, with 1.74% growth. This brings the company's revenue in the last twelve months to 19.63M, up 85.91% year-over-year. In the year 2024, ProQR Therapeutics had annual revenue of 19.55M with 196.41% growth.

• Revenue (ttm): 19.63M EUR
• Revenue Growth: +85.91%
• P/S Ratio: 8.42
• Revenue / Employee: 118,158 EUR
• Employees: 166
• Market Cap: 214.90M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	19.55M	12.95M	196.41%
Dec 31, 2023	6.59M	2.24M	51.27%
Dec 31, 2022	4.36M	1.98M	83.31%
Dec 31, 2021	2.38M	1.35M	131.10%
Dec 31, 2020	1.03M	-904.00K	-46.77%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.